Your browser doesn't support javascript.
loading
Cisplatin can be safely administered to ovarian cancer patients with hypersensitivity to carboplatin.
Bergamini, A; Pisano, C; Di Napoli, M; Arenare, L; Della Pepa, C; Tambaro, R; Facchini, G; Gargiulo, P; Rossetti, S; Mangili, G; Pignata, S; Cecere, S C.
Affiliation
  • Bergamini A; Department of Urology and Gynaecology, Istituto Nazionale Tumori, Fondazione G. Pascale, IRCCS, Naples, Italy; Department of Obstetrics and Gynecology, IRCCS San Raffaele Hospital, Via Olgettina 60, Milan, Italy.
  • Pisano C; Department of Urology and Gynaecology, Istituto Nazionale Tumori, Fondazione G. Pascale, IRCCS, Naples, Italy.
  • Di Napoli M; Department of Urology and Gynaecology, Istituto Nazionale Tumori, Fondazione G. Pascale, IRCCS, Naples, Italy.
  • Arenare L; Department of Urology and Gynaecology, Istituto Nazionale Tumori, Fondazione G. Pascale, IRCCS, Naples, Italy.
  • Della Pepa C; Department of Urology and Gynaecology, Istituto Nazionale Tumori, Fondazione G. Pascale, IRCCS, Naples, Italy.
  • Tambaro R; Department of Urology and Gynaecology, Istituto Nazionale Tumori, Fondazione G. Pascale, IRCCS, Naples, Italy.
  • Facchini G; Department of Urology and Gynaecology, Istituto Nazionale Tumori, Fondazione G. Pascale, IRCCS, Naples, Italy.
  • Gargiulo P; Department of Urology and Gynaecology, Istituto Nazionale Tumori, Fondazione G. Pascale, IRCCS, Naples, Italy.
  • Rossetti S; Department of Urology and Gynaecology, Istituto Nazionale Tumori, Fondazione G. Pascale, IRCCS, Naples, Italy.
  • Mangili G; Department of Obstetrics and Gynecology, IRCCS San Raffaele Hospital, Via Olgettina 60, Milan, Italy.
  • Pignata S; Department of Urology and Gynaecology, Istituto Nazionale Tumori, Fondazione G. Pascale, IRCCS, Naples, Italy. Electronic address: s.pignata@istitutotumori.na.it.
  • Cecere SC; Department of Urology and Gynaecology, Istituto Nazionale Tumori, Fondazione G. Pascale, IRCCS, Naples, Italy.
Gynecol Oncol ; 144(1): 72-76, 2017 Jan.
Article de En | MEDLINE | ID: mdl-28094039

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de l'ovaire / Protocoles de polychimiothérapie antinéoplasique / Carboplatine / Cisplatine / Hypersensibilité médicamenteuse / Récidive tumorale locale Type d'étude: Observational_studies / Risk_factors_studies Limites: Aged / Female / Humans / Middle aged Langue: En Journal: Gynecol Oncol Année: 2017 Type de document: Article Pays d'affiliation: Italie Pays de publication: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de l'ovaire / Protocoles de polychimiothérapie antinéoplasique / Carboplatine / Cisplatine / Hypersensibilité médicamenteuse / Récidive tumorale locale Type d'étude: Observational_studies / Risk_factors_studies Limites: Aged / Female / Humans / Middle aged Langue: En Journal: Gynecol Oncol Année: 2017 Type de document: Article Pays d'affiliation: Italie Pays de publication: États-Unis d'Amérique